Our findings are in line with those of previous studies indicating that the loss of PR expression correlates with aggressive tumor characteristics (Arpino et al. 2005, Olivier et al. 2006) and with a gene signature of the PI3K/Akt/mTOR pathway (Creighton et al. 2009). The gene discussed is PGR; the disease is neoplasm.